Retatrutide is a triple-receptor agonist, the first of its kind to simultaneously activate GLP-1, GIP, and glucagon receptors
"The risk of depression, anxiety, and suicidal behavior in patients with obesity on glucagon like peptide-1 receptor agonist therapy." Scientific Reports 14.1 (2024): 24433
The Journal of Neuroscience
Discard medication that appears cloudy, discolored, contains particles or crystals, or has separated into layers
Pricing as the Differentiator: With both drugs proving immensely effective, price has become the primary tool for winning patients
Profile 7: Patients Requiring In-Person Medication Management for Comorbidities Patients on warfarin, narrow therapeutic index drugs, or insulin regimens that will require dose titration as weight changes should be managed by an in-person prescriber who can order labs, adjust doses, and monitor for interactions in real time